Barclays’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18M | Buy |
+38,000
| New | +$19.1M | ﹤0.01% | 1149 |
|
|
2025
Q4 | – | Sell |
-19,100
| Closed | -$8.14M | – | 5412 |
|
|
2025
Q3 | $8.14M | Sell |
19,100
-3,600
| -16% | -$1.4M | ﹤0.01% | 1823 |
|
|
2025
Q2 | $8.7M | Buy |
+22,700
| New | +$8.18M | ﹤0.01% | 1681 |
|
|
2023
Q1 | – | Sell |
-3,600
| Closed | -$864K | – | 5195 |
|
|
2022
Q4 | $864K | Buy |
+3,600
| New | +$806K | ﹤0.01% | 2933 |
|
|
2021
Q4 | – | Sell |
-2,800
| Closed | -$680K | – | 4382 |
|
|
2021
Q3 | $680K | Hold |
2,800
| – | – | ﹤0.01% | 3021 |
|
|
2021
Q2 | $579K | Sell |
2,800
-4,400
| -61% | -$897K | ﹤0.01% | 2998 |
|
|
2021
Q1 | $1.36M | Sell |
7,200
-9,400
| -57% | -$1.66M | ﹤0.01% | 2581 |
|
|
2020
Q4 | $2.73M | Hold |
16,600
| – | – | ﹤0.01% | 1998 |
|
|
2020
Q3 | $2.07M | Hold |
16,600
| – | – | ﹤0.01% | 2068 |
|
|
2020
Q2 | $1.61M | Sell |
16,600
-9,900
| -37% | -$1.03M | ﹤0.01% | 2325 |
|
|
2020
Q1 | $2.38M | Sell |
26,500
-71,300
| -73% | -$9.23M | ﹤0.01% | 2136 |
|
|
2019
Q4 | $14.5M | Sell |
97,800
-3,800
| -4% | -$510K | 0.01% | 1149 |
|
|
2019
Q3 | $12.2M | Buy |
101,600
+33,100
| +48% | +$4.28M | 0.01% | 1161 |
|
|
2019
Q2 | $9.26M | Buy |
68,500
+54,300
| +382% | +$6.87M | 0.01% | 1407 |
|
|
2019
Q1 | $1.85M | Sell |
14,200
-42,100
| -75% | -$5.65M | ﹤0.01% | 2657 |
|
|
2018
Q4 | $7.01M | Sell |
56,300
-29,700
| -35% | -$3.99M | 0.01% | 1365 |
|
|
2018
Q3 | $12M | Sell |
86,000
-73,600
| -46% | -$9.16M | 0.01% | 1161 |
|
|
2018
Q2 | $16.4M | Sell |
159,600
-41,800
| -21% | -$4.23M | 0.01% | 891 |
|
|
2018
Q1 | $19.5M | Buy |
201,400
+1,700
| +0.9% | +$165K | 0.01% | 856 |
|
|
2017
Q4 | $17.5M | Buy |
199,700
+93,600
| +88% | +$7.52M | 0.01% | 875 |
|
|
2017
Q3 | $8.44M | Buy |
106,100
+20,300
| +24% | +$1.63M | 0.01% | 1158 |
|
|
2017
Q2 | $7.48M | Sell |
85,800
-66,500
| -44% | -$5.63M | 0.01% | 1174 |
|
|
2017
Q1 | $13.6M | Buy |
152,300
+39,400
| +35% | +$3.29M | 0.01% | 714 |
|
|
2016
Q4 | $8.36M | Buy |
112,900
+90,600
| +406% | +$6.79M | 0.01% | 1043 |
|
|
2016
Q3 | $1.69M | Sell |
22,300
-24,600
| -52% | -$1.88M | ﹤0.01% | 2137 |
|
|
2016
Q2 | $3.61M | Sell |
46,900
-10,900
| -19% | -$860K | ﹤0.01% | 1547 |
|
|
2016
Q1 | $4.51M | Buy |
57,800
+7,400
| +15% | +$517K | 0.01% | 1259 |
|
|
2015
Q4 | $3.38M | Buy |
50,400
+18,900
| +60% | +$1.32M | ﹤0.01% | 1596 |
|
|
2015
Q3 | $2.43M | Sell |
31,500
-1,595,900
| -98% | -$141M | ﹤0.01% | 1948 |
|
|
2015
Q2 | $146M | Buy |
1,627,400
+1,586,600
| +3,889% | +$127M | 0.16% | 93 |
|
|
2015
Q1 | $3.06M | Sell |
40,800
-36,600
| -47% | -$2.63M | ﹤0.01% | 1944 |
|
|
2014
Q4 | $5.65M | Buy |
77,400
+48,200
| +165% | +$3.39M | 0.01% | 1594 |
|
|
2014
Q3 | $2.04M | Buy |
29,200
+17,400
| +147% | +$1.15M | ﹤0.01% | 2645 |
|
|
2014
Q2 | $661K | Buy |
11,800
+600
| +5% | +$31.7K | ﹤0.01% | 3719 |
|
|
2014
Q1 | $582K | Sell |
11,200
-35,700
| -76% | -$1.78M | ﹤0.01% | 3805 |
|
|
2013
Q4 | $2.21M | Sell |
46,900
-44,400
| -49% | -$2.05M | ﹤0.01% | 2570 |
|
|
2013
Q3 | $3.83M | Buy |
91,300
+11,600
| +15% | +$453K | ﹤0.01% | 1915 |
|
|
2013
Q2 | $2.87M | Buy |
+79,700
| New | +$3.08M | ﹤0.01% | 2136 |
|
Other funds holding HCA
VCM
VPM
Barclays's HCA Position: Q1 2026 in Review
Barclays reduced its HCA Healthcare (HCA) stake by 5.6% in Q1 2026, selling an estimated $37.2M and leaving 1,248,315 shares worth $591M. The position accounts for 0.14% of the portfolio, ranked #110.
Barclays first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. The position peaked at $617M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Barclays held 1,248,315 shares of HCA Healthcare worth $591M as of Q1 2026.
- Barclays sold 73,896 HCA Healthcare shares in Q1 2026, an estimated $37.2M.
- HCA Healthcare made up 0.14% of Barclays's portfolio in Q1 2026, its #110 holding.
- Barclays first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- Barclays's HCA Healthcare position peaked at $617M in Q4 2025.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.